We have shown previously that priming of respiratory mucosa with live Lactobacillus species promotes robust and prolonged survival from an otherwise lethal infection with pneumonia virus of mice, a property known as heterologous immunity. Lactobacillus priming results in a moderate reduction in virus recovery and a dramatic reduction in virus-induced proinflammatory cytokine production; the precise mechanisms underlying these findings remain to be elucidated. Because B cells have been shown to promote heterologous immunity against respiratory virus pathogens under similar conditions, in this study we explore the role of B cells in Lactobacillus-mediated protection against acute pneumovirus infection. We found that Lactobacillus-primed mice feature elevated levels of airway Igs IgG, IgA, and IgM and lung tissues with dense, B cell (B220 + )-enriched peribronchial and perivascular infiltrates with germinal centers consistent with descriptions of BALT. No B cells were detected in lung tissue of Lactobacillus-primed B cell deficient mMT mice or Jh mice, and Lactobacillus-primed mMT mice had no characteristic infiltrates or airway Igs. Nonetheless, we observed diminished virus recovery and profound suppression of virus-induced proinflammatory cytokines CCL2, IFN-g, and CXCL10 in both wild-type and Lactobacillus-primed mMT mice. Furthermore, Lactobacillus plantarum-primed, B cell-deficient mMT and Jh mice were fully protected from an otherwise lethal pneumonia virus of mice infection, as were their respective wild-types. We conclude that B cells are dispensable for Lactobacillus-mediated heterologous immunity and were not crucial for promoting survival in response to an otherwise lethal pneumovirus infection. The Journal of Immunology, 2014, 192: 000-000. I nflammatory responses to the human pneumovirus pathogen, respiratory syncytial virus (RSV), can be strong and persistent, beyond the control of conventional antiviral and anti-inflammatory therapies, resulting in profound negative consequences for the host (reviewed in Ref. 1). Pneumonia virus of mice (PVM), a rodent pneumovirus pathogen closely related to RSV, serves as a model of severe respiratory virus infection and is an important platform for exploring immunomodulatory therapy and disease prevention (2, 3) . No single mouse model can reproduce all features of human disease or represent the full spectrum of human experience; however, unlike RSV challenge-clearance models in mice, PVM undergoes robust replication in mouse lung tissue, elicits disease-relevant outcomes, and fulfills Koch's postulates for a host/ pathogen relationship in rodent species.
I nflammatory responses to the human pneumovirus pathogen, respiratory syncytial virus (RSV), can be strong and persistent, beyond the control of conventional antiviral and anti-inflammatory therapies, resulting in profound negative consequences for the host (reviewed in Ref. 1) . Pneumonia virus of mice (PVM), a rodent pneumovirus pathogen closely related to RSV, serves as a model of severe respiratory virus infection and is an important platform for exploring immunomodulatory therapy and disease prevention (2, 3) . No single mouse model can reproduce all features of human disease or represent the full spectrum of human experience; however, unlike RSV challenge-clearance models in mice, PVM undergoes robust replication in mouse lung tissue, elicits disease-relevant outcomes, and fulfills Koch's postulates for a host/ pathogen relationship in rodent species.
In previous work, we described important immunomodulatory properties of Gram-positive Lactobacillus species at the respiratory mucosa (4, 5) . Specifically, we found that priming of the respiratory tract of wild-type mice with Lactobacillus plantarum or Lactobacillus reuteri promoted both profound and sustained protection against an otherwise lethal PVM infection. These observations represent a robust example of heterologous immunity, also known as innate imprinting, or trained immunity, concepts that have been invoked to explain increased resistance (or in some cases, susceptibility) to an unrelated infection observed upon recovery from a primary innate immune or inflammatory response (6) (7) (8) (9) . There are numerous examples of these observations in the literature. Among them, several groups have reported that mice vaccinated against tuberculosis with bacillus Calmette-Guérin (BCG) were protected against infections with antigenically unrelated pathogens, including Gram-positive bacteria, the fungus Candida albicans, and the parasite Schistosoma mansoni (reviewed in Ref. 6); analgous findings have been reported in BCG-vaccinated children (10) . Heterologous immunity has also been invoked to explain the increased susceptibility to infection with Streptococcus pneumoniae observed among patients recovering from severe influenza infection (reviewed in Ref. 11) .
In an effort to elucidate the mechanisms underlying heterologous immunity to lethal respiratory virus infection, we have evaluated the molecular and cellular inflammatory responses generated in situ in lung tissue of Lactobacillus-primed mice. Among these findings, mice primed with Lactobacillus and subsequently challenged with PVM respond with moderate suppression of virus recovery together with diminished expression of an array of proinflammatory cytokines (4) .
Interestingly, Harmsen and colleagues (12, 13) recently reported that protein cage nanoparticles, multisubunit immunostimulatory molecules derived from the small heat shock protein of the thermophilic bacteria Methanocaldococcus jannaschii, promote B celldependent heterologous immunity in mice against a wide variety of respiratory virus pathogens, including PVM. Specifically, protein cage nanoparticles induced accelerated adaptive immunity to virus pathogens (13) in association with the formation of BALT, a tertiary lymphoid structure induced in response to microbial and/ or inflammatory provocation that features germinal center B cells, follicular dendritic cells, and T cells (14) (15) (16) (17) .
In our earlier work, we found that Lactobacillus-mediated priming of the mouse respiratory tract also resulted in the induction of peribronchiolar and perivascular cuff-like infiltrates, consistent with histological descriptions of BALT (4) . With this information, together with the larger understanding of B cells as immunomodulatory and antiviral mediators, including production of natural IgM (18), Abindependent support of macrophages (19) , and production of the antiinflammatory cytokine IL-10 (20), our goal was to determine whether B cells played a crucial role in Lactobacillus priming and protection elicited against lethal respiratory virus infection.
Materials and Methods

Mouse strains
Wild-type C57BL/6 and BALB/c mice were purchased from the Division of Cancer Therapeutics, National Cancer Institute (Frederick, MD). B celldeficient mouse strains used include mMT mice (The Jackson Laboratory, stock 2288; C57BL/6 background) (21) and Jh mice (Taconic; BALB/c background) (22) . All mouse studies were approved by National Institute of Allergy and Infectious Diseases and carried out in accordance with National Institute of Allergy and Infectious Diseases Institutional Animal Care and Use Committee Guidelines.
Lactobacillus
Cultures of L. plantarum NCIMB 8826 (ATCC BAA-793) were grown overnight in MRS broth at 37˚C in a shaker incubator. Bacteria were washed in sterile PBS and resuspended at 2 3 10 10 CFU/ml (4) in sterile PBS with 0.1% BSA for intranasal inoculation under isoflurane anesthesia. Each mouse received 50 ml of this dilution or 50 ml PBS with 0.1% BSA diluent control per inoculation, which reaches both upper and lower respiratory tracts (23) at days 214 and 27 of the protocol (see timeline in Fig. 1A ). For the experiment involving heat-inactivated L. plantarum, live cultures grown and washed as above were resuspended in a minimal volume of PBS, heated to 95˚C for 10 min in a thermocycler, and then frozen in a dry ice/ethanol bath; this was repeated for a total of three cycles. Heat-inactivated bacteria were then resuspended in PBS with 0.1% BSA at 10 11 CFU/ml (determined as per original live titration) (4) and stored at 280˚C prior to use at appropriate dilution. For experiments in which mice were provided with L. plantarum in drinking water, bacteria were grown overnight as above, washed, and resuspended at 10 9 live CFU/ml in standard drinking water (250/ml/cage). Mice were provided with fresh drinking water (with freshly cultured live bacteria) every 3 d for 2 wk prior to PVM inoculation and for the remaining period thereafter. Mice were weighed every 3 d prior to PVM inoculation to ascertain appropriate water intake throughout.
Virus
Fifty percent tissue culture-infective dose assays (24) provided quantitative evaluation of mouse-passaged PVM J3666 stocks. Infections were established 9 CFU L. plantarum/ml drinking water for 2 wk prior to inoculation with PVM on day 0; n = 15 mice/group. in isoflurane-anesthetized mice via intranasal inoculation with 0.2-2 fifty percent tissue culture-infective dose units in 50 ml DMEM diluent.
Virus recovery
Virus recovery was determined from cDNA generated from total RNA from mouse lung tissue via a dual standard curve quantitative RT-PCR method targeting the PVM SH gene and mouse GAPDH that generates absolute copy numbers per copy GAPDH (PVM SH /GAPDH) as previously described (4).
ELISAs
Cytokine ELISAs (R&D Systems, Minneapolis, MN) were performed on clarified homogenates of lung tissue and corrected for total protein by BCA assay. Ig ELISAs (Kamiya Biomedicals, Seattle, WA) were performed on bronchoalveolar lavage fluids. All kits were used as per manufacturers' instructions.
Flow cytometry
Lung tissue was harvested and single-cell suspensions were prepared as previously described (4, 5) . Live/Dead stain (Invitrogen) was added to the cells and Ab binding to Fc receptors was blocked with anti-mouse CD16/ CD32. Cells were then stained with anti-CD3-FITC, anti-CD19-V450, and anti-GR1-allophycocyanin in PBS with 0.1% BSA at 4˚C for 1 h and washed with this buffer prior to analysis. All Abs were purchased from BD Biosciences (Durham, NC). A minimum of 100,000 events were collected on an LSR II flow cytometer (BD Biosciences) and findings were analyzed in 
Immunohistochemistry
Tissue sections prepared from 10% phosphate-buffered formalin-fixed lung tissue were stained with H&E. Unstained sections were probed with purified rabbit polyclonal anti-RGS13 Ab (25) , rat anti-mouse B220 mAb (mAb1217; R&D Systems) or appropriate control Abs followed by peroxidase-conjugated anti-Ig and developing reagents (Histoserv, Germantown, MD).
Statistical analysis
Data were analyzed using Mann-Whitney U test and one-way ANOVA as appropriate.
Results
Priming of the respiratory tract with L. plantarum results in protection from the lethal sequelae of PVM infection and generation of dense lymphocytic infiltrates in mouse lung tissue
As reported in our previous publications (4, 5) , BALB/c mice primed via intranasal inoculation with live L. plantarum (10 9 CFU/mouse on days 214 and 27) are fully protected against the lethal sequelae of a subsequent PVM infection (Fig. 1A) . Lactobacillus-mediated protection is associated with diminished virus recovery from lung tissue (Fig. 1B) , although we have shown previously that virus recovery is not a strong predictor of the degree of protection elicited by Lactobacillus priming (4, 5) . Heat-inactivated Lactobacillus is also protective against the lethal sequelae of acute PVM infection (4) . In this study, we show that heat-inactivated L. plantarum can protect against the lethal sequelae of infection even when PVM inoculation is delayed for 4 wk, from day 0 to day 28. As shown in 
we observed no protection against the lethal sequelae of PVM infection among mice receiving L. plantarum in drinking water (10 9 CFU/ml for 2 wk prior to PVM inoculation on day 0; Fig. 1D ).
Lung tissues from L. plantarum-primed mice feature dense mononuclear cell infiltrates at the airways and blood vessels ( Fig.  2A-C) , consistent with descriptions of BALT (14) . The infiltrates are enriched with B cells (B220 + ; Fig. 2D ) and also can also be detected with RGS13, a marker for germinal center B cells (Fig. 2E,  2F) . Likewise, elevated levels of total IgG (Fig. 3A) , IgA (Fig. 3B) , and IgM (Fig. 3B) were detected in the airways of L. plantarumprimed mice.
Lactobacillus priming and PVM infection in B cell-deficient mice
To explore the possibility that B cells play a role in heterologous immunity promoted by Lactobacillus priming, we examined the results of L. plantarum priming and PVM infection two B celldeficient mouse strains, including mMT (C57BL/6 background) in which targeting of the Cm locus results in arrested development at the pre-B cell stage (21) and Jh (BALB/c background) in which a similar phenotype results from the deletion of four J H segments from the H chain locus (22) (Fig. 4A, 4B) ; T cell recruitment (CD3 + CD19 2 ) persisted despite the B cell deficiency (Fig. 4C) . Similarly, no B cells were detected in lung tissue from L. plantarum-primed, PVM-infected B celldeficient Jh mice (Fig. 4D-F) . Similar to what we observed in BALB/c mice, C57BL/6 mice also respond to Lactobacillus priming and PVM infection by developing prominent infiltrates (Fig. 5A) enriched with (B220 + ) B cells (Fig. 5B) . No infiltrates are detected in L. plantarumprimed, PVM-infected B cell-deficient mMT mice (Fig. 5C, 5D) . Likewise, analogous to what we observed in L. plantarum-primed BALB/c mice (Fig. 3A) , elevated levels of total IgG were detected in the airways of L. plantarum-primed C57BL/6 mice; no IgG was detected in the airways of B cell-deficient mMT mice (Fig. 5E) . Similar results were obtained for total IgM and IgA (data not shown).
Virus recovery and survival of L. plantarum-primed, PVM-infected wild-type and B cell-deficient mice
We observed no statistically significant differences in virus recovery when comparing wild-type and B cell-deficient (mMT) mice; Lactobacillus priming resulted in 0.5-0.8 log reductions in virus recovery in both wild-type and B cell-deficient strains (Fig. 6A) . Similarly, as shown in Fig. 6B , B cell deficiency has no impact on Lactobacillus-promoted survival from an otherwise lethal respiratory virus infection. All control (PBS/BSA) primed PVM-infected mice died between days 7 and 11, and all L. plantarum-primed PVM-infected mice survived throughout (p , 0.001).
Cytokine responses of B cell-deficient mice
Although virus recovery and survival responses of B cell-deficient mice are indistinguishable from those of their wild-type counterparts, patterns of cytokine suppression are not fully superimposable. Specifically, L. plantarum priming prior to virus infection results in profound suppression of both CCL2 (Fig. 7A) and CXCL10 (Fig. 7B ) in both wild-type and mMT mice. Suppression of IFN-g is also observed in both strains, although significantly more of this cytokine is produced in response to PVM infection in B cell-deficient mice (Fig. 7C) ; we have shown previously that IFN-g is not a crucial mediator of L. plantarum-mediated protection against PVM infection (5). In contrast, CXCL1, which undergoes substantial suppression in Lactobacillus-primed, PVMinfected mice, is not a major feature of the response to PVM infection in the mMT strain (Fig. 7D) . Finally, IL-10, a prominent anti-inflammatory cytokine produced by regulatory B cells (20) as well as by monocytes, is not detected in response to Lactobacillus priming in wild-type or B cell-deficient mMT mice (Fig. 7E) .
Discussion
From these studies, we conclude that B cells are dispensable for Lactobacillus-mediated heterologous immunity and have no role in promoting survival in response to an otherwise lethal respiratory virus infection.
As noted earlier, heterologous immunity, also known in other contexts as innate imprinting, and trained immunity (6) (7) (8) (9) are concepts that explain increased (or decreased) resistance to unrelated infections that result from primary innate immune or inflammatory response. Netea et al. (7) introduced the term "trained immunity" as a means to explain and to explore nonspecific crossprotection to unrelated microbes. Among these findings, as noted earlier, were observations documenting systemic exposure to attenuated Mycobacterium tuberculosis (BCG vaccination) that resulted in nonspecific systemic immunity to several unrelated pathogens (reviewed in Ref. 6 ). BCG-mediated macrophage activation and antimicrobial peroxide production was initially implicated in this mechanism (26). Kleinnijenhuis et al. (27) recently reported that nonspecific protection elicited by BCG vaccination in human subjects was directly dependent on persistent, NOD2-dependent epigenetic alterations in circulating monocytes, specifically altered histone methylation patterns, and that BCG vaccination likewise elicited induction of proinflammatory cytokines IFN-g, TNF-a, and IL-1b.
Lactobacillus priming of the respiratory mucosa and protection generated against PVM infection is another dramatic example of this concept, as we observe not only robust but ongoing and sustained protection against an unrelated respiratory virus pathogen (4, 5). Specifically, we have shown that significant protection against a lethal inoculum of PVM can be sustained for 5 mo or longer after only two intranasal inoculations of L. plantarum. Interestingly, as we compare our findings to the aforementioned results of Kleinnijenhuis et al. (27) , we find that Lactobacillus The Journal of Immunologypriming of the respiratory mucosa is similarly associated with induction of proinflammatory cytokines IFN-g and TNF-a, although we found in our earlier work that IFN-g was dispensable for heterologous immunity (i.e., survival in response to subsequent PVM challenge) (5) . Interestingly, and in contrast to findings with BCG vaccination (27) , preliminary results from our laboratory indicate that heterologous immunity elicited in response to Lactobacillus priming of the respiratory mucosa is not directly dependent on the presence of the pattern recognition receptor NOD2 (H.F. Rosenberg, unpublished results).
There are several intriguing examples of heterologous immunity elicited by microbial agents via direct priming at the respiratory mucosa that likewise appear to proceed via distinct mechanisms. For example, Clement, Tuvim, Evans, and colleagues (28) (29) (30) (31) have examined immunity generated in mice subjected to multiple instillations of a sterile lysate from the Gram-negative microorganism nontypeable Haemophilus influenza (NTHi). Similar to our findings, they have reported that intranasal NTHi results in protection from the lethal sequelae of influenza A infection. However, in contrast to immunity elicited by Lactobacillus priming against PVM (4, 5) , protection elicited by the NTHi infusions is short-lived, results in a prominent type I IFN response, and is dependent on epithelial cell-specific MyD88 signaling. Thus, although direct priming with either NTHi or Lactobacillus serves to promote protection against acute respiratory virus infection, the cellular and biochemical mechanisms promoting these responses are clearly distinct and stimulus-specific.
Likewise, several groups have shown that intranasal administration of Lactobacillus species, using a variety of priming strategies, also protects mice against acute influenza infection (32, 33), similar to our findings with PVM (4, 5) . Interestingly, oral administration of at least three distinct Lactobacillus strains has also been reported as effective against the lethal sequelae of influenza (34) (35) (36) . These results are significantly at odds with our findings with PVM, in which we document that prolonged oral administration of L. plantarum has no impact whatsoever on survival (Fig. 1C) . It would be intriguing to determine the source of these different results and what the underlying mechanisms might be.
In this study, we focused on a role for B cells in promoting heterologous immunity. Apart from their role in adaptive immunity, specific B cell subsets have also been implicated in antiviral host defense. For example, Choi and Baumgarth (37) and Jayasekera et al. (38) demonstrated that B1a cells play important roles in innate immunity to influenza infection by production of virusneutralizing nonspecific IgM. Similarly, as reported by Moseman et al. (19) , B cell-derived lymphotoxin a 1 b 2 was necessary to support subcapsular sinus macrophages within draining lymph nodes, thus preventing fatal infection with vesicular stomatitis virus. B cells are also among the crucial components of BALT, which are tertiary lymphoid structures that develop in mouse lung tissue in response to inflammatory and/or microbial provocation (14) (15) (16) (17) . Classic BALT has a structured organization with distinct T and B cell areas, with the latter including follicular dendritic cells and proliferative germinal centers, although variants with primarily B cells (39) or intermixed zones (14) have been described. We have shown in the present study that the lymphoid clusters induced by L. plantarum include both B220-positive mature B cells as well as RGS13-positive cells, shown by Shi et al. (40) to be a specific marker for germinal center B cells.
As noted earlier, Harmsen and colleagues (12, 13) found that otherwise unmanipulated mice primed with protein cage nanoparticles, multisubunit particles derived from bacterial heat-shock proteins, developed BALT; furthermore, they reported that B cellmediated immunomodulatory mechanisms, including accelerated generation of Igs in situ, were crucial to bacterial/protein-mediated protection against respiratory virus pathogens. Interestingly, we find that although Lactobacillus priming induces the formation of B cell-enriched infiltrates with germinal centers, Lactobacillusmediated protection proceeds via mechanisms that are B cell independent. In contrast to results obtained with protein cage nanoparticle priming and influenza (12) , in which diminished virus recovery was B cell dependent, we determined that virus recovery after PVM infection is diminished in both L. plantarumprimed B cell-deficient and wild-type strains. Furthermore, survival of Lactobacillus-primed, PVM infected B cell-deficient mice was indistinguishable from that of their wild-type counterparts. It is again intriguing to find that such fundamentally different mechanisms promote what are otherwise similar outcomes.
In summary, we have shown that mice primed via intranasal inoculation with L. plantarum are protected against subsequent PVM infection. We show in the present study that L. plantarum priming elicits formation infiltrates enriched with B lymphocytes and elevated levels of Igs in the airways. Although B cells have been implicated in promoting heterologous immunity against PVM and other respiratory virus infections (12), L. plantarumprimed, PVM-infected B cell-deficient mice respond with diminished virus recovery, indistinguishable from their wild-type counterparts. Furthermore, L. plantarum-primed, B cell-deficient mice are fully protected from the lethal sequelae of PVM infection. We conclude that B cell deficiency has no impact on these important outcomes underlying heterologous immunity promoted uniquely via Lactobacillus priming at the respiratory mucosa.
